NCT01460134 · Interventional trial
A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers
Overall registry status Completed
Phase 1
Conditions Any T-cell Malignancy, Burkett's Lymphoma, CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Colorectal Adenocarcinoma, Non-small Cell Lung Cancer), Hormone-refractory Prostate Adenocarcinoma, Ovarian Cancer, Mantle Cell Lymphoma, Marginal Zone B Cell Lymphoma), Primary Lymphoma of the Central Nervous System, Solid Tumors (Metastatic Melanoma, Renal (Clear) Cell Carcinoma
Delaware Valley sites
- University of Pennsylvania Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory